Trial Search Results

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity

The purpose of this trial was to determine the efficacy and safety of supplemental therapeutic oxygen for infants with prethreshold retinopathy of prematurity (ROP) to reduce the probability of progression to threshold ROP and the need for peripheral retinal ablation.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

NICHD Neonatal Research Network

Collaborator: Research to Prevent Blindness

Stanford Investigator(s):

Intervention(s):

  • Procedure: Supplemental Oxygen Management
  • Procedure: Conventional Oxygen Management

Phase:

Phase 2/Phase 3

Eligibility


Inclusion Criteria:

   - Infants with prethreshold retinopathy of prematurity, confirmed by 2 certified
   ophthalmologic exams

   - Median pulse oxygen saturation <94% in room air

   - Median pulse oxygen saturation can be kept safely >96% on oxygen/ventilator

Exclusion Criteria:

   - No fatal congenital anomaly or congenital eye anomaly

Ages Eligible for Study

N/A - 48 Hours

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting